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Abstract
Objective: Current American Heart Association (AHA) guidelines
for pre-participation athletic screening recommend a 12-point
history and exam to minimize the risk of sudden cardiac death.
We tested the hypothesis that focused cardiac ultrasound (FCU)
performed and simultaneously interpreted by a cardiologist using a
handheld ultrasound device would be a feasible addition.
Methods: We performed pre-participation screening according to
AHA recommendations on high school athletes in a multi-purpose
room at their school. In addition to the standard 12-point assessment,
a cardiologist simultaneously performed and interpreted a FCU on
each athlete using a handheld ultrasound.
Results: The mean age of the athletes was 16.6 ± 3.4 years;
68% were male. No evidence of left ventricular hypertrophy,
cardiomyopathy, bicuspid aortic valve, or aortopathy was identified.
Coronary ostia could not be visualized. Echocardiography added
1.35 ± 0.51 minutes to the standard exam.
Conclusion: This feasibility study suggests that the addition of
handheld echocardiography with real-time interpretation performed
by a cardiologist to a standard AHA pre-participation screening
adds less than two minutes of time to the assessment. While the
study is not as comprehensive as an office based echocardiogram,
it can provide valuable information which may be useful in ruling
out some of the most common causes of sudden cardiac death
in the young athlete or in selecting those who would benefit from
further testing.
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Introduction
While the incidence of sudden cardiac death (SCD) in athletes
throughout the country is relatively small, ranging from 1:341,551
participants in high school sports in Minnesota to up to 1:3,100
male NCAA Division I Basketball players, the emotional impact of
even one death is devastating not only for the family, but also for
the town or university [1,2]. Although we have learned a great deal
regarding the various causes of SCD, the data remain scarce for
effective preventative measures. The American Heart Association
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(AHA) recommends pre-participation screening, which consists of
a 12 point history and physical exam [3]. It is not necessary that the
screening be performed by a physician and the screening has not
been shown to impact mortality.
We sought to determine whether the addition of focused
cardiac ultrasound (FCU) with real-time interpretation was a
feasible addition to pre-participation screening in a multi-purpose
room setting. Europe and the International Olympic Committee
have mandated inclusion of screening electrocardiograms in preparticipation screening, based on the Italian experience in Veneto,
Italy [4]. This study showed that inclusion of screening ECGs
decreased the incidence of SCD in Italian athletes by 89% compared
to non-screened non-athletes [5]. However, the results of the study
are controversial and have not borne out in Israel or when compared
to the United States experience [6,7]. A recent cost effectiveness
projection of the Italian model to high school and college athletes in
the United States suggests that a 20 year program would save 4,813
lives at a cost of 10.6-14.4 million dollars per life saved [8]. In addition
to the financial limitations, widespread ECG usage as a screening
tool is encumbered by difficulty with interpretation. Furthermore,
normal or near-normal ECGs can be seen in 10% of patients with
HCM (false negatives) [9].
The routine performance of an echocardiogram is not mandated,
except in a relatively few forums. At this point, only 13% of
professional sports teams incorporate echocardiography, although
the number is higher for basketball [10]. At the NCAA Division I
level in football, a group of athletes with a relatively high risk of SCD,
only 23% of programs responding to a survey reported screening
echocardiography [11]. Feasibility of full echocardiograms on a mass
scale is limited by time, space and financial resources.
Development of handheld echocardiography enabling FCU
could drastically change the role for screening echocardiograms.
Good concordance of the measurements typically required for the
diagnosis of hypertrophic cardiomyopathy, as well as assessment of
valvular regurgitation have been observed between handheld and
standard echocardiography [12,13]. The most recent guidelines
on FCU put forth by the American Society of Echocardiography
incorporate the use of eFCU – defined as FCU performed by an
experienced echo cardiographer – as a reasonable means by which to
diagnose hypertrophic cardiomyopathy in an athletic screening [14].
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Figure 1: Handheld device used to perform focused cardiac ultrasound.

Methods
Two cardiologists and one cardiology fellow performed a
pre-participation screening in a multi-purpose room at a public
high school. Vital signs were obtained by two volunteer registered
nurses. The standard AHA 12 point pre-participation history and
physical exams were performed. FCU images were obtained by a
level II trained cardiologist with a General Electric Vscan handheld
echocardiogram (GE Healthcare, Wauwatosa, WI). Vscan is a 1.4 ×
7.3 × 2.8cm device weighing 390g with an 8.9cm diagonal, 240 × 320
pixel display (Figure 1). Vscan uses a phased-array transducer (1.73.8MHz) with a fixed sector angle of 75° and maximum depth of 25
cm. Color flow Doppler is available within a 30° maneuverable sector.
Spectral Doppler or M-mode imaging is not available with the device.
Images are stored on the device as JPEG still captures or MPEG-4
cine loops.
Subjects lay supine and parasternal long-axis views were obtained
with and without color Doppler. Short axis views were obtained at
the level of the aortic valve, mitral valve, papillary muscles and left
ventricular apex. Apical windows were obtained in subjects with
prior cardiac history or abnormal physical exam. Abnormal findings
at point-of-care analysis or off-line analysis would lead to referral of
the subject to their pediatrician for full evaluation.
Subsequent off-line analysis of the images was performed on
a Vscan Gateway workstation version 1.0.0.12 (GE Healthcare).
Measurements of the wall thickness of the interventricular septum
and posterior wall of the left ventricle were measured, as well as the
dimensions of the left ventricle. Ejection fraction was also calculated.
The presence and severity of mitral and aortic regurgitation was
assessed. The presence of a bicuspid aortic valve was ascertained
and the diameter of the aortic root was measured. Coronary artery
origins were not assessed. This protocol was approved by The George
Washington University Institutional Review Board.

Statistical analysis
Results are expressed as the mean ± standard deviation or as
absolute values or percentages, as appropriate.

Results
A total of 68 athletes underwent Vscan echocardiography. The
mean age of the athletes was 16.6 ± 3.4 years and 68% were male.
The majority of the high school athletes played soccer (41%), followed
by cross country (21%), cheerleading (13%), volleyball (11%), tennis
(6.5%), field hockey (4.3%) and golf (2.2%). Echocardiography added
only 1.35 ± 0.51 minutes to the standard exam. No abnormalities were
noted real-time by the scanning and interpreting cardiologist (Figure
2). Subsequent offline analysis showed that the mean thickness
of the septum and posterior wall were 0.69 ± 0.15cm and 0.72 ±
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Figure 2a: Parasternal long axis view of the heart.
Figure 2b: Short axis view of the heart at the level of the mitral valve.

0.13cm, respectively. The mean left ventricular internal dimension
(in diastole) was 4.2 ± 0.48cm. No evidence of left ventricular
hypertrophy, cardiomyopathy, bicuspid aortic valve, or aortopathy
was identified on any of the echocardiograms. Coronary ostia could
not be visualized.

Discussion
The standard AHA screening exam alone is extremely lacking
in sensitivity. Two recent studies found that screening with history
and physical alone is associated with a sensitivity of less than 50%
which is generally considered unacceptable for a screening test
[15,16]. The addition of an electrocardiogram to the standard exam
does increase sensitivity (to about 90%), while decreasing specificity
(from 76.4% and 94.1% to 69.5% and 82.7%, respectively). It is clear
that while an electrocardiogram may strengthen the effectiveness of
screening, mass screening requires bulky equipment and can result
in unnecessary downstream testing in the setting of more frequent
false positive screening results. When a standard screening and an
electrocardiogram suggest an abnormality, the next diagnostic test is
echocardiography. Incorporating the echocardiogram at the outset,
especially in a high risk population, may be a cost effective solution.
There are limitations to the data acquired by echocardiography.
First, while hypertrophic cardiomyopathy is the most common
cause of sudden cardiac death in the young athlete, it is not the only
cause and a normal echocardiogram may cause false reassurance. In
addition, cardiovascular exam by FCU is not as complete as standard
echocardiography, and should not be considered as a replacement.
FCU does not have the capacity for spectral and tissue Doppler, which
are crucial for hemodynamic assessment, evaluation of outflow tract
obstruction and diastolic function. Diastolic function is one of the key
distinguishing characteristics between a physiologically remodeled
athlete’s heart and hypertrophic cardiomyopathy. Especially without
concurrent electrocardiographic testing, we would recommend full
standard echocardiography for athletes who screen positive based on
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the 12 point AHA pre-participation screening or in those with any
concerning findings on their FCU.
Cost effectiveness is already debated for screening
electrocardiograms. In our case, the FCU was performed and
simultaneously interpreted by an experienced cardiologist,
volunteering with a group of cardiologists without additional costs
beyond the fixed cost of the device. This fulfills the vision of the FCU
serving as an extension of the physical exam. The inclusion of the FCU
could reduce unnecessary downstream testing, as the echocardiogram
is considered the first evaluation subsequent to an abnormal
electrocardiogram in pre-participation screening. Currently eFCU
is a non-reimbursable procedure requiring an expert to volunteer
time and a device - a possibly insurmountable logistical boundary for
widespread screening.
Our study demonstrates that it is feasible to incorporate FCU into
pre-participation screening. It requires very little additional space and
equipment, and can be done in an ordinary room, adding minimal
time to the examination. Given that the echocardiogram is so
frequently performed in downstream testing, immediate performance
and interpretation of echocardiograms in a mass screening setting
could add valuable information to the screening process. More
research is still needed to assess the efficacy and cost effectiveness of
FCU in the screening of the elite athlete at higher risk for SCD.
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